ZNF16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.868430E-01
Normal-vs-Stage2
8.801600E-01
Normal-vs-Stage3
3.988200E-01
Normal-vs-Stage4
3.583200E-01
Stage1-vs-Stage2
1.799950E-01
Stage1-vs-Stage3
1.021910E-02
Stage1-vs-Stage4
7.424000E-01
Stage2-vs-Stage3
2.271200E-01
Stage2-vs-Stage4
1.528370E-01
Stage3-vs-Stage4
8.907800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.981000E-01
Normal-vs-AfricanAmerican
6.476400E-01
Normal-vs-Asian
9.478800E-01
Caucasian-vs-AfricanAmerican
3.152200E-01
Caucasian-vs-Asian
7.405400E-01
AfricanAmerican-vs-Asian
5.377000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.336000E-01
Normal-vs-Female
8.136800E-01
Male-vs-Female
9.789600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.510600E-01
Normal-vs-Age(41-60Yrs)
5.996000E-01
Normal-vs-Age(61-80Yrs)
9.756600E-01
Normal-vs-Age(81-100Yrs)
4.905600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.500600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.519600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.502200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.762400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.518600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.531700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.418600E-01
Normal-vs-Daily Drinker
9.571400E-01
Normal-vs-Weekly Drinker
9.526000E-01
Normal-vs-Occasional Drinker
3.463000E-01
Normal-vs-Social Drinker
9.288000E-01
Non Drinker-vs-Daily Drinker
7.934200E-01
Non Drinker-vs-Weekly Drinker
7.920200E-01
Non Drinker-vs-Occasional Drinker
1.889930E-02
Non Drinker-vs-Social Drinker
5.739200E-01
Daily Drinker-vs-Weekly Drinker
9.933200E-01
Daily Drinker-vs-Occasional Drinker
3.492000E-02
Daily Drinker-vs-Social Drinker
8.016400E-01
Weekly Drinker-vs-Occasional Drinker
5.401600E-02
Weekly Drinker-vs-Social Drinker
7.967800E-01
Occasional Drinker-vs-Social Drinker
5.964100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.232000E-01
Normal-vs-Grade 2
6.978500E-02
Normal-vs-Grade 3
3.235900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.762600E-01
Grade 1-vs-Grade 3
3.259600E-01
Grade 1-vs-Grade 4
2.232000E-01
Grade 2-vs-Grade 3
5.161900E-02
Grade 2-vs-Grade 4
6.978500E-02
Grade 3-vs-Grade 4
3.235900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.928600E-01
Normal-vs-NonDiabetic
8.036400E-01
Diabetic-vs-NonDiabetic
3.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.311000E-01
Normal-vs-NoPancreatitis
8.061400E-01
Pancreatitis-vs-NoPancreatitis
7.191600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.594800E-01
Normal-vs-N1
8.822800E-01
N0-vs-N1
3.411400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.424000E-01
Normal-vs-TP53-NonMutant
7.822000E-01
TP53-Mutant-vs-TP53-NonMutant
5.242300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
